Vericiguat reduced a composite of CV death or HF...

Vericiguat reduced a composite of CV death or HF hospitalization in patients with HF and reduced LVEF.

Abstract

SOURCE CITATION: Armstrong PW, Pieske B, Anstrom KJ, et al. Vericiguat in patients with heart failure and reduced ejection fraction. N Engl J Med. 2020;382:1883-93. 32222134.

Authors

Averbuch T; Van Spall HGC

Journal

Annals of Internal Medicine, Vol. 173, No. 6,

Publisher

American College of Physicians

Publication Date

September 15, 2020

DOI

10.7326/acpj202009150-030

ISSN

1056-8751

Associated Experts

Harriette Van Spall

Associate Professor, FHSMED

Visit profile

Labels